Pantoprazol A-Med (Pantoprazole)

Pantoprazole, the active ingredient in Pantoprazol A-Med, is a proton pump inhibitor presented as a strength/form for oral use. It reduces stomach acid production and is used to treat conditions such as gastro‑oesophageal reflux disease and peptic ulcer disease in adults.

GNH USA supplies Pantoprazol A-Med as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Pantoprazol A-Med is a proton pump inhibitor that acts on the gastric acid secretion pathway. It is indicated for: - Gastro‑oesophageal reflux disease (GERD): relief of heartburn and erosion healing. - Erosive esophagitis: promotes healing of erosions in the esophagus. - Peptic ulcer disease: supports ulcer healing and reduces recurrence. - Zollinger‑Ellison syndrome: controls gastric acid hypersecretion.

Pantoprazol A-Med may cause a range of adverse reactions. Most are mild and resolve after discontinuation.

Common Side Effects: - Headache: mild to moderate intensity. - Diarrhea: loose stools without blood. - Nausea: feeling of stomach upset. - Abdominal pain: cramping or discomfort. - Flatulence: excess gas. - Constipation: reduced bowel movements.

Serious or Rare Side Effects: - Clostridioides difficile infection: severe colitis with watery diarrhea. - Acute interstitial nephritis: kidney inflammation presenting with reduced urine output. - Severe hypersensitivity: rash, itching, swelling, or anaphylaxis. - Osteoporosis‑related fractures: increased risk with long‑term use. - Hypomagnesemia: low magnesium levels causing muscle cramps or arrhythmia.

When prescribing Pantoprazol A-Med, clinicians should consider several safety aspects. - Assess renal function: dose adjustment may be needed in severe impairment. - Review concomitant medications: potential for altered absorption of drugs requiring acidic pH. - Monitor long‑term users: watch for bone density loss and magnesium levels. - Pregnancy and lactation: use only if clearly needed after risk‑benefit evaluation. - Discontinue before surgery: consider stopping to reduce risk of postoperative infections. - Store at ambient temperature: keep below 25°C, retain original packaging, and protect from moisture.

Pantoprazol A-Med can affect the pharmacokinetics of several co‑administered medicines.

Major Interactions (Avoid): - Antifungal azoles (ketoconazole, itraconazole): reduced absorption due to increased gastric pH. - HIV protease inhibitors (atazanavir, nelfinavir): decreased plasma concentrations. - Clopidogrel: diminished antiplatelet effect.

Moderate Interactions (Monitor Closely): - Warfarin: potential increase in INR; monitor coagulation. - Methotrexate (high dose): reduced renal clearance; check serum levels. - Digoxin: possible increase in serum concentration; observe for toxicity.